Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07212166 · ClinicalTrials.gov registry record
A Study of Questionnaires in Adolescents and Young Adults With Cancer
A clinical trial of Adolescents and Young Adults With Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 120
- Enrollment target
- 7
- Study locations
NCT07212166: Recruiting study of Adolescents and Young Adults With Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
NCT07212166 is a study of Adolescents and Young Adults With Cancer that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 120 participants. The trial reports 7 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07212166, a study of Adolescents and Young Adults With Cancer, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to evaluate a questionnaire called PRO-AYA: Patient-Reported Outcomes for Adolescents and Young Adults.
Primary Outcome
The test-retest reliability will be based on the intraclass correlation (ICC) coefficients between the baseline and follow-up domain scores of PRO-AYA.
Conditions Studied
Interventions
- OTHER Patient-Reported Outcome Surveys
- OTHER Spanish version of PRO-AYA and the cognitive interview
Study Locations (7)
New York
- Memorial Sloan Kettering Commack (Consent Only) - Commack
- Memorial Sloan Kettering Westchester (Consent Only) - Harrison
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering Nassau (Consent Only) - Uniondale
New Jersey
- Memorial Sloan Kettering Basking Ridge (Consent Only) - Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent Only) - Middletown
- Memorial Sloan Kettering Bergen (Consent Only) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-09-30 |
| Est. Completion | 2026-09-30 |
What NCT07212166 shows while recruiting
NCT07212166 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Adolescents and Young Adults With Cancer appearing as the primary indexed condition, and to 2 interventions - of which Patient-Reported Outcome Surveys is the first listed.
NCT07212166 lists 7 locations in 2 states (New York, New Jersey).
Frequently Asked Questions
What is clinical trial NCT07212166 about?
NCT07212166 is a clinical study titled "A Study of Questionnaires in Adolescents and Young Adults With Cancer". The purpose of this study is to evaluate a questionnaire called PRO-AYA: Patient-Reported Outcomes for Adolescents and Young Adults.
What is the current status of trial NCT07212166?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2025-09-30. Estimated completion is 2026-09-30.
What conditions does trial NCT07212166 study?
This clinical trial studies the following conditions: Adolescents and Young Adults With Cancer.
What interventions are being tested in trial NCT07212166?
The interventions under investigation include: Patient-Reported Outcome Surveys (OTHER), Spanish version of PRO-AYA and the cognitive interview (OTHER).
Who is sponsoring clinical trial NCT07212166?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07212166 being conducted?
This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI